Results 11 to 20 of about 714 (167)

[Tricuspid regurgitation: transcatheter treatment by TriClip®]. [PDF]

open access: yesRevue medicale de Liege, 2022
Tricuspid regurgitation (TR) is not rare and has been associated with poor clinical outcomes when severe. The etiology of TR is functional in most cases and is usually associated with left-sided valvular heart disease. Severe TR is responsible for right heart failure and may evolve to global heart failure.
P, Lancellotti   +5 more
core   +16 more sources

Dos sistemas TriClip simultáneos como técnica de rescate [PDF]

open access: yesREC: Interventional Cardiology
Mujer de 66 años con regurgitación tricuspídea funcional torrencial con gran separación entre valvas septal-anterior, aceptada para tratamiento percutáneo borde a borde.
Manuel Luna-Morales   +4 more
doaj   +7 more sources

Comparative analysis of MitraClip/TriClip and PASCAL in transcatheter tricuspid valve repair for tricuspid regurgitation: a systematic review and meta-analysis [PDF]

open access: yesBMC Cardiovascular Disorders
Background The edge-to-edge transcatheter tricuspid valve repair (TTVR) has emerged as a promising technique for the treatment of tricuspid regurgitation (TR).
Mahmoud Balata   +3 more
doaj   +3 more sources

Two simultaneous TriClip systems as a bailout technique

open access: yesREC: Interventional Cardiology (English Ed.)
A 66-year-old woman with severe functional tricuspid regurgitation and significant septal-anterior leaflet separation was admitted for transcatheter edge-to-edge repair.
Manuel Luna-Morales   +4 more
doaj   +3 more sources

Percutaneous Edge-to-Edge Tricuspid Valve Repair in a Patient with Cor Triatriatum Dexter: A Case Report

open access: yesJournal of Cardiovascular Development and Disease, 2021
Background: Tricuspid regurgitation is gaining importance due to its high morbidity and mortality. Especially in the elderly, novel technologies in percutaneous therapies have become valuable options due to the commonly present high surgical risk.
Fabian Barbieri   +5 more
doaj   +2 more sources

Transcatheter Tricuspid Valve Clinical Trials: Incomplete Data and FDA-Approved Devices

open access: yesStructural Heart
Each reviewed trial of transcatheter tricuspid valve intervention demonstrated clinically meaningful improvement in Kansas City Cardiomyopathy Questionnaire (KCCQ)-defined quality of life and favorable right ventricular remodeling.
Deborah Furman, MD, Brian Whisenant, MD
doaj   +2 more sources

Short-Term Outcomes of Tricuspid Edge-to-Edge Repair in Clinical Practice. [PDF]

open access: yes, 2023
BACKGROUND Severe tricuspid regurgitation (TR) is known to be associated with substantial morbidity and mortality. OBJECTIVES The authors sought to study the acute outcomes of subjects treated by tricuspid transcatheter edge-to-edge repair with the ...
Bekeredjian, Raffi   +14 more
core   +4 more sources

Concomitant Transcatheter Edge-to-Edge Repair for Mitral and Tricuspid Regurgitation for Polyvalvular Disease. [PDF]

open access: yesCatheter Cardiovasc Interv
ABSTRACT This patient is a 77‐year‐old male with non‐ischemic cardiomyopathy, severe tricuspid regurgitation, and moderate mitral regurgitation who underwent simultaneous transcatheter edge‐to‐edge repair of both mitral and tricuspid valves. Post‐procedure, the patient exhibited significant symptomatic improvement and reduced regurgitation severity ...
Khan O, Summers M.
europepmc   +2 more sources

Two-Year Outcomes for Tricuspid Repair With a Transcatheter Edge-to-Edge Valve Repair From the Transatlantic TRILUMINATE Trial [PDF]

open access: yes, 2023
BACKGROUND Tricuspid regurgitation (TR) is a common and progressive valve disease with significant mortality and hospitalization burden. Tricuspid transcatheter edge-to-edge repair provides a treatment option for high-risk patients with primary and ...
Sitges, Marta   +139 more
core   +3 more sources

Home - About - Disclaimer - Privacy